152 related articles for article (PubMed ID: 11845986)
1. Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice.
Hlubinová K; Hlavatý J; Altaner C
Neoplasma; 2001; 48(5):398-406. PubMed ID: 11845986
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
Kokoris MS; Sabo P; Adman ET; Black ME
Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
[TBL] [Abstract][Full Text] [Related]
4. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
5. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
[TBL] [Abstract][Full Text] [Related]
7. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B
Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells.
Namba H; Iwadate Y; Kawamura K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Jun; 8(6):414-20. PubMed ID: 11498761
[TBL] [Abstract][Full Text] [Related]
10. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
11. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
[TBL] [Abstract][Full Text] [Related]
12. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
13. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K
Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837
[TBL] [Abstract][Full Text] [Related]
14. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
Walling HW; Swarthout JT; Culver KW
Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
[TBL] [Abstract][Full Text] [Related]
15. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir.
Wang S; Qi J; Smith M; Link CJ
Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238
[TBL] [Abstract][Full Text] [Related]
17. Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells.
Grignet-Debrus C; Calberg-Bacq CM
Gene Ther; 1997 Jun; 4(6):560-9. PubMed ID: 9231072
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
[TBL] [Abstract][Full Text] [Related]
19. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
[TBL] [Abstract][Full Text] [Related]
20. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]